Caicun Zhou

Caicun Zhou

UNVERIFIED PROFILE

Are you Caicun Zhou?   Register this Author

Register author
Caicun Zhou

Caicun Zhou

Publications by authors named "Caicun Zhou"

Are you Caicun Zhou?   Register this Author

100Publications

2657Reads

22Profile Views

Galectin-9 in non-small cell lung cancer.

Lung Cancer 2019 Oct 16;136:80-85. Epub 2019 Aug 16.

Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University Medical School Cancer Institute, Tongji University School of Medicine, No. 507 Zhengmin Road, Shanghai, 200433, People's Republic of China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2019.08.014DOI Listing
October 2019

EGFR-targeted therapy alters the tumor microenvironment in EGFR-driven lung tumors: Implications for combination therapies.

Int J Cancer 2019 Sep 19;145(5):1432-1444. Epub 2019 Feb 19.

Department of Medical Oncology, Shanghai Pulmonary Hospital & Thoracic Cancer Institute, Tongji University School of Medicine, Shanghai, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.32191DOI Listing
September 2019

Value of heart rate recovery in female patients with pulmonary arterial hypertension due to systemic lupus erythematosus.

Clin Respir J 2019 Sep 27;13(9):545-554. Epub 2019 Aug 27.

Department of Pulmonary Function Test, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/crj.13056DOI Listing
September 2019

Tumor neoantigens: from basic research to clinical applications.

J Hematol Oncol 2019 Sep 6;12(1):93. Epub 2019 Sep 6.

Department of Medical Oncology, Shanghai Pulmonary Hospital & Thoracic Cancer Institute, Tongji University School of Medicine, No. 507, Zheng Min Road, Shanghai, 200433, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13045-019-0787-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731555PMC
September 2019

Impact of EGFR-TKIs combined with PD-L1 antibody on the lung tissue of EGFR-driven tumor-bearing mice.

Lung Cancer 2019 Sep 19;137:85-93. Epub 2019 Sep 19.

Department of Medical Oncology, Shanghai Pulmonary Hospital & Thoracic Cancer Institute, Tongji University School of Medicine, Shanghai, 200433, PR China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2019.09.016DOI Listing
September 2019

Major histocompatibility complex class II molecule in non-small cell lung cancer diagnosis, prognosis and treatment.

Onco Targets Ther 2019 5;12:7281-7288. Epub 2019 Sep 5.

Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University Medical School Cancer Institute, Tongji University School of Medicine, Shanghai 200433, People's Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/OTT.S214231DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6733341PMC
September 2019

OX40 (CD134) and OX40 ligand, important immune checkpoints in cancer.

Onco Targets Ther 2019 6;12:7347-7353. Epub 2019 Sep 6.

Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University Medical School Cancer Institute, Tongji University School of Medicine, Shanghai 200433, People's Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/OTT.S214211DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6735535PMC
September 2019

EGFR-TKIs plus bevacizumab demonstrated survival benefit than EGFR-TKIs alone in patients with EGFR-mutant NSCLC and multiple brain metastases.

Eur J Cancer 2019 Sep 27;121:98-108. Epub 2019 Sep 27.

Department of Medical Oncology, Shanghai Pulmonary Hospital & Thoracic Cancer Institute, Tongji University School of Medicine, Shanghai, China; Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2019.08.021DOI Listing
September 2019

OX40 and OX40L protein expression of tumor infiltrating lymphocytes in non-small cell lung cancer and its role in clinical outcome and relationships with other immune biomarkers.

Transl Lung Cancer Res 2019 Aug;8(4):352-366

Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University Medical School Cancer Institute, Tongji University School of Medicine, Shanghai 200433, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/tlcr.2019.08.15DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6749115PMC
August 2019

Branched-Chain Amino Acid Metabolic Reprogramming Orchestrates Drug Resistance to EGFR Tyrosine Kinase Inhibitors.

Cell Rep 2019 Jul;28(2):512-525.e6

State Key Laboratory of Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China; CAS Center for Excellence in Molecular Cell Science, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China; Innovation Center for Cell Signaling Network, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China; Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai 200433, China; School of Life Science and Technology, Shanghai Tech University, Shanghai 200120, China; University of Chinese Academy of Sciences, Beijing 100049, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2019.06.026DOI Listing
July 2019

Genomic landscape and its correlations with tumor mutational burden, PD-L1 expression, and immune cells infiltration in Chinese lung squamous cell carcinoma.

J Hematol Oncol 2019 Jul 12;12(1):75. Epub 2019 Jul 12.

Department of Medical Oncology, Shanghai Pulmonary Hospital & Thoracic Cancer Institute, Tongji University School of Medicine, Zheng Min Road, Shanghai, 200433, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13045-019-0762-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6625041PMC
July 2019

Association Between Nicotine-dependent Gene Polymorphism and Smoking Cessation in Patients With Lung Cancer.

Clin Lung Cancer 2019 Jul 17. Epub 2019 Jul 17.

Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2019.07.002DOI Listing
July 2019

Protective effects of hesperetin on lipopolysaccharide-induced acute lung injury by targeting MD2.

Eur J Pharmacol 2019 Jun 23;852:151-158. Epub 2019 Feb 23.

Department of Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai 200433, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejphar.2019.02.042DOI Listing
June 2019

Clinical features and therapeutic options in non-small cell lung cancer patients with concomitant mutations of EGFR, ALK, ROS1, KRAS or BRAF.

Cancer Med 2019 Jun 24;8(6):2858-2866. Epub 2019 Apr 24.

Department of Lung Cancer and Immunology, Shanghai Pulmonary Hospital, Tongji University, Shanghai, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.2183DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558647PMC
June 2019

Alectinib versus crizotinib in untreated Asian patients with anaplastic lymphoma kinase-positive non-small-cell lung cancer (ALESIA): a randomised phase 3 study.

Lancet Respir Med 2019 May 10;7(5):437-446. Epub 2019 Apr 10.

Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-2600(19)30053-0DOI Listing
May 2019

High feasibility of cytological specimens for detection of fusion by reverse transcriptase PCR in Chinese patients with advanced non-small-cell lung cancer.

Onco Targets Ther 2019 1;12:3305-3311. Epub 2019 May 1.

Department of Medical Oncology, Shanghai Pulmonary Hospital & Thoracic Cancer Institute, Tongji University School of Medicine, Shanghai 200433, People's Republic of China,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/OTT.S198827DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501702PMC
May 2019

Low-Dose Apatinib Optimizes Tumor Microenvironment and Potentiates Antitumor Effect of PD-1/PD-L1 Blockade in Lung Cancer.

Cancer Immunol Res 2019 Apr 12;7(4):630-643. Epub 2019 Feb 12.

Department of Medicine, Division of Medical Oncology and Department of Pathology, University of Colorado Cancer Center, Aurora, Colorado.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-17-0640DOI Listing
April 2019

Antibiotics are associated with attenuated efficacy of anti-PD-1/PD-L1 therapies in Chinese patients with advanced non-small cell lung cancer.

Lung Cancer 2019 04 31;130:10-17. Epub 2019 Jan 31.

Department of Medical Oncology, Shanghai Pulmonary Hospital &Thoracic Cancer Institute, Tongji University School of Medicine, Shanghai, 200433, PR China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2019.01.017DOI Listing
April 2019

Clinical value of neutrophil-to-lymphocyte ratio in patients with non-small-cell lung cancer treated with PD-1/PD-L1 inhibitors.

Lung Cancer 2019 04 10;130:76-83. Epub 2019 Feb 10.

Department of Medical Oncology, Shanghai Pulmonary Hospital, Thoracic Cancer Institute, Tongji University School of Medicine, Shanghai, 200433, PR China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2019.02.009DOI Listing
April 2019

Re-biopsy and liquid biopsy for patients with non-small cell lung cancer after EGFR-tyrosine kinase inhibitor failure.

Thorac Cancer 2019 Apr 18;10(4):957-965. Epub 2019 Mar 18.

Department of Medical Oncology, Shanghai Pulmonary Hospital & Thoracic Cancer Institute, Tongji University School of Medicine, Shanghai, China.

View Article

Download full-text PDF

Source
https://onlinelibrary.wiley.com/doi/abs/10.1111/1759-7714.13
Publisher Site
http://dx.doi.org/10.1111/1759-7714.13035DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449239PMC
April 2019

Arbutin attenuates LPS-induced lung injury via Sirt1/ Nrf2/ NF-κBp65 pathway.

Pulm Pharmacol Ther 2019 02 6;54:53-59. Epub 2018 Dec 6.

The Third Affiliated Hospital of Soochow University, Changzhou, 213000, China; Department of Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, 200433, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pupt.2018.12.001DOI Listing
February 2019

Loss of T790M mutation is associated with early progression to osimertinib in Chinese patients with advanced NSCLC who are harboring EGFR T790M.

Lung Cancer 2019 02 12;128:33-39. Epub 2018 Dec 12.

Department of Medical Oncology, Shanghai Pulmonary Hospital &Thoracic Cancer Institute, Tongji University School of Medicine, Shanghai, 200433, PR China. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01695002183069
Publisher Site
http://dx.doi.org/10.1016/j.lungcan.2018.12.010DOI Listing
February 2019

Risk factors for nicotine dependence in Chinese patients with lung cancer.

J Int Med Res 2019 Jan 10;47(1):391-397. Epub 2018 Oct 10.

3 Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0300060518802738DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6384457PMC
January 2019

First-line continual EGFR-TKI plus local ablative therapy demonstrated survival benefit in EGFR-mutant NSCLC patients with oligoprogressive disease.

J Cancer 2019 1;10(2):522-529. Epub 2019 Jan 1.

Department of Oncology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, People's Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7150/jca.26494DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360299PMC
January 2019

A Phase II Clinical Trial of Apatinib in Pretreated Advanced Non-squamous Non-small-cell Lung Cancer.

Clin Lung Cancer 2018 11 27;19(6):e831-e842. Epub 2018 Jun 27.

Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15257304183016
Publisher Site
http://dx.doi.org/10.1016/j.cllc.2018.06.002DOI Listing
November 2018

Impact of serum vascular endothelial growth factor and interleukin-6 on treatment response to epidermal growth factor receptor tyrosine kinase inhibitors in patients with non-small-cell lung cancer.

Lung Cancer 2018 11 31;125:22-28. Epub 2018 Aug 31.

Department of Medical Oncology, Shanghai Pulmonary Hospital & Thoracic Cancer Institute, Tongji University School of Medicine, Shanghai, 200433, PR China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2018.08.025DOI Listing
November 2018

Dual integrin αvβ 3 and NRP-1-Targeting Paramagnetic Liposome for Tumor Early Detection in Magnetic Resonance Imaging.

Nanoscale Res Lett 2018 Nov 27;13(1):380. Epub 2018 Nov 27.

Department of Medical Oncology, Shanghai Pulmonary Hospital and Thoracic Cancer Institute, Tongji University School of Medicine, No. 507, Zheng Min Road, Shanghai, 200433, People's Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s11671-018-2797-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258593PMC
November 2018

PD-L1 expression and its effect on clinical outcomes of EGFR-mutant NSCLC patients treated with EGFR-TKIs.

Cancer Biol Med 2018 Nov;15(4):434-442

Department of General and Oncological Pulmonology, University Clinical Hospital Norbert Barlicki, Medical University of Lodz, Lodz 50243, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.20892/j.issn.2095-3941.2018.0223DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372913PMC
November 2018

TIM-3, a promising target for cancer immunotherapy.

Onco Targets Ther 2018 16;11:7005-7009. Epub 2018 Oct 16.

Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

View Article

Download full-text PDF

Source
https://www.dovepress.com/tim-3-a-promising-target-for-cance
Publisher Site
http://dx.doi.org/10.2147/OTT.S170385DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198883PMC
October 2018

The combination of anti-KIR monoclonal antibodies with anti-PD-1/PD-L1 monoclonal antibodies could be a critical breakthrough in overcoming tumor immune escape in NSCLC.

Drug Des Devel Ther 2018 24;12:981-986. Epub 2018 Apr 24.

Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

View Article

Download full-text PDF

Source
https://www.dovepress.com/the-combination-of-anti-kir-monocl
Publisher Site
http://dx.doi.org/10.2147/DDDT.S163304DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5923225PMC
September 2018

Consolidative Local Ablative Therapy Improves the Survival of Patients With Synchronous Oligometastatic NSCLC Harboring EGFR Activating Mutation Treated With First-Line EGFR-TKIs.

J Thorac Oncol 2018 09 29;13(9):1383-1392. Epub 2018 May 29.

Department of Oncology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, People's Republic of China; Department of Lung Cancer and Immunology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864183063
Publisher Site
http://dx.doi.org/10.1016/j.jtho.2018.05.019DOI Listing
September 2018

Detection of EGFR mutations in plasma circulating tumour DNA as a selection criterion for first-line gefitinib treatment in patients with advanced lung adenocarcinoma (BENEFIT): a phase 2, single-arm, multicentre clinical trial.

Lancet Respir Med 2018 09 17;6(9):681-690. Epub 2018 Jul 17.

State Key Laboratory of Molecular Oncology, Department of Medical Oncology, National Cancer Center and Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-2600(18)30264-9DOI Listing
September 2018

A miRNA Panel Predicts Sensitivity of FGFR Inhibitor in Lung Cancer Cell Lines.

Clin Lung Cancer 2018 09 28;19(5):450-456. Epub 2018 Jun 28.

Department of Medicine, Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2018.06.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339511PMC
September 2018

sLAG-3 in non-small-cell lung cancer patients' serum.

Onco Targets Ther 2018 13;11:4781-4784. Epub 2018 Aug 13.

Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/OTT.S164178DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097502PMC
August 2018

CNS Response to Osimertinib Versus Standard Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients With Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer.

J Clin Oncol 2018 Aug 28:JCO2018783118. Epub 2018 Aug 28.

Thanyanan Reungwetwattana, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand; Kazuhiko Nakagawa, Kindai University School of Medicine, Osaka; Naoyuki Nogami, National Hospital Organization Shikoku Cancer Center, Matsuyama; Isamu Okamoto, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; Byoung Chul Cho, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul; Eun Kyung Cho, Gachon University Gil Medical Center, Incheon; Ki Hyeong Lee, Chungbuk National University Hospital, Cheong-ju, Republic of Korea; Manuel Cobo, Institute of Biomedical Research in Málaga, Málaga University Hospital Regional, Málaga, Spain; Alessandro Bertolini, Hospital of Sondrio, Sondrio, Italy; Sabine Bohnet, Universitätsklinik Schleswig-Holstein, Lübeck, Germany; Caicun Zhou, Pulmonary Hospital of Tongji University, Shanghai, People's Republic of China; Natasha Leighl, Princess Margaret Cancer Centre, Toronto, Ontario, Canada; Rachel Hodge, Astrid McKeown, Andrew P. Brown, and Yuri Rukazenkov, AstraZeneca, Cambridge, United Kingdom; Suresh S. Ramalingam, Winship Cancer Institute, Emory University, Atlanta, GA; and Johan Vansteenkiste, University Hospital, Katholieke Universiteit Leuven, Leuven, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2018.78.3118DOI Listing
August 2018

Lung cancer in never smokers-the East Asian experience.

Transl Lung Cancer Res 2018 Aug;7(4):450-463

Department of Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai 200433, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/tlcr.2018.05.14DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6131183PMC
August 2018

Serum microRNAs improving the diagnostic accuracy in lung cancer presenting with pulmonary nodules.

J Thorac Dis 2018 Aug;10(8):5080-5085

Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

View Article

Download full-text PDF

Source
http://jtd.amegroups.com/article/view/23629/17841
Publisher Site
http://dx.doi.org/10.21037/jtd.2018.07.138DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6129919PMC
August 2018

A consensus on the role of osimertinib in non-small cell lung cancer from the AME Lung Cancer Collaborative Group.

J Thorac Dis 2018 Jul;10(7):3909-3921

Department of Medical Oncology, Shanghai Pulmonary Hospital, Thoracic Cancer Institute, Tongji University School of Medicine, Shanghai 200433, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/jtd.2018.07.61DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6106007PMC
July 2018

Establishment of patient-derived tumor spheroids for non-small cell lung cancer.

PLoS One 2018 15;13(3):e0194016. Epub 2018 Mar 15.

Department of Respiration, The Second Affiliated Hospital of Soochow University, Suzhou, P.R. China.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0194016PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5854348PMC
June 2018

Pretreatment neutrophil-to-lymphocyte ratio is associated with outcome of advanced-stage cancer patients treated with immunotherapy: a meta-analysis.

Cancer Immunol Immunother 2018 May 8;67(5):713-727. Epub 2018 Feb 8.

Department of Medical Oncology, Shanghai Pulmonary Hospital, Thoracic Cancer Institute, Tongji University School of Medicine, No. 507, Zheng Min Road, Shanghai, 200433, People's Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-018-2126-zDOI Listing
May 2018

Shining light on advanced NSCLC in 2017: combining immune checkpoint inhibitors.

J Thorac Dis 2018 May;10(Suppl 13):S1534-S1546

Department of Medical Oncology, Shanghai Pulmonary Hospital & Thoracic Cancer Institute, Tongji University School of Medicine, Shanghai 200433, China.

View Article

Download full-text PDF

Source
http://jtd.amegroups.com/article/view/20952/16428
Publisher Site
http://dx.doi.org/10.21037/jtd.2018.04.99DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994489PMC
May 2018

Impact of Clinicopathologic Features on the Efficacy of PD-1/PD-L1 Inhibitors in Patients With Previously Treated Non-small-cell Lung Cancer.

Clin Lung Cancer 2018 03 9;19(2):e177-e184. Epub 2017 Nov 9.

Department of Medical Oncology, Shanghai Pulmonary Hospital, Thoracic Cancer Institute, Tongji University School of Medicine, Shanghai, People's Republic of China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2017.10.018DOI Listing
March 2018

Successful treatment using apatinib with or without docetaxel in heavily pretreated advanced non-squamous non-small cell lung cancer: A case report and literature review.

Cancer Biol Ther 2018 03 15;19(3):141-144. Epub 2018 Jan 15.

a Department of Medical Oncology , Shanghai Pulmonary Hospital, Tongji University School of Medicine , Shanghai , China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/15384047.2017.1414757DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790342PMC
March 2018

Comprehensive evaluation of NT5E/CD73 expression and its prognostic significance in distinct types of cancers.

BMC Cancer 2018 03 7;18(1):267. Epub 2018 Mar 7.

Department of Medical Oncology, Shanghai Pulmonary Hospital, Thoracic Cancer Institute, Tongji University School of Medicine, No. 507, Zheng Min Road, Shanghai, 200433, People's Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-018-4073-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5842577PMC
March 2018

Outcomes of Pemetrexed-based chemotherapies in HER2-mutant lung cancers.

BMC Cancer 2018 03 27;18(1):326. Epub 2018 Mar 27.

Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Tongji University Medical School Cancer Institute, No. 507 Zheng Min Road, Shanghai, 200433, People's Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-018-4277-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5869778PMC
March 2018

Long non-coding RNA UCA1 promotes lung cancer cell proliferation and migration via microRNA-193a/HMGB1 axis.

Biochem Biophys Res Commun 2018 02 31;496(2):738-745. Epub 2018 Jan 31.

Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University of Medicine, Tongji University Medical School Cancer Institute, Tongji University, Shanghai, People's Republic of China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2018.01.097DOI Listing
February 2018

Distinct clinicopathologic features, genomic characteristics and survival of central and peripheral pulmonary large cell neuroendocrine carcinoma: From different origin cells?

Lung Cancer 2018 02 15;116:30-37. Epub 2017 Dec 15.

Department of Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2017.12.009DOI Listing
February 2018

Combination Strategies on the Basis of Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer: Where Do We Stand?

Clin Lung Cancer 2018 01 23;19(1):1-11. Epub 2017 Jun 23.

Department of Medical Oncology, Shanghai Pulmonary Hospital and Thoracic Cancer Institute, Tongji University School of Medicine, Shanghai, PR China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2017.06.005DOI Listing
January 2018

Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer.

N Engl J Med 2018 01 18;378(2):113-125. Epub 2017 Nov 18.

From Gustave Roussy Cancer Campus and University Paris-Sud, Orsay, France (J.-C.S., D.P.); the Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo (Y.O.), the Department of Thoracic Oncology, Osaka International Cancer Institute (F.I.), and the Department of Thoracic Oncology, Kansai Medical University Hospital (T.K.), Osaka, the Department of Thoracic Oncology, National Hospital Organization Shikoku Cancer Center, Matsuyama (N.N.), and the Research Institute for Diseases of the Chest, Graduate School of Medical Science, Kyushu University, Fukuoka (I.O.) - all in Japan; the Respiratory Oncology Unit, University Hospital KU Leuven, Leuven, Belgium (J.V.); Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok (T.R.), the Oncology Unit, Department of Medicine, Chiang Mai University, Chiang Mai (B.C.), and the Division of Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Hat Yai (A.D.) - all in Thailand; the Division of Medical Oncology, Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheong-ju (K.H.L.), the Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul (B.C.C.), and the Division of Hematology and Oncology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon (E.K.C.) - all in South Korea; Pulmonary Hospital of Tongji University, Shanghai (C.Z.), and Jilin Provincial Cancer Hospital, Changchun (Y.C.) - both in China; Hospital Umum Sarawak, Kuching, Malaysia (P.J.V.); National Cheng Kung University, Tainan, Taiwan (W.-C.S.); the Department of Thoracic Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL (J.E.G.); the Department of Oncology, University College London Hospitals Biomedical Research Centre, and the Cancer Research UK Lung Cancer Centre of Excellence, London (S.-M.L.), and AstraZeneca, Cambridge (R.H., M.M., Y.R.) - all in the United Kingdom; and Emory University School of Medicine, Winship Cancer Institute, Atlanta (S.S.R.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1713137DOI Listing
January 2018

Prognostic value of PD-L1 expression in combination with CD8 TILs density in patients with surgically resected non-small cell lung cancer.

Cancer Med 2018 01 23;7(1):32-45. Epub 2017 Nov 23.

Department of Medical Oncology, Shanghai Pulmonary Hospital & Thoracic Cancer Institute, Tongji University School of Medicine, Shanghai, 200433, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.1243DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5773962PMC
January 2018

Characterization of never-smoking and its association with clinical outcomes in Chinese patients with small-cell lung cancer.

Lung Cancer 2018 01 26;115:109-115. Epub 2017 Nov 26.

Department of Medical Oncology, Shanghai Pulmonary Hospital & Thoracic Cancer Institute, Tongji University School of Medicine, Shanghai, 200433, PR China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2017.11.022DOI Listing
January 2018

Histone deacetylation, as opposed to promoter methylation, results in epigenetic silencing and resistance to EGFR TKI in NSCLC.

Oncol Lett 2018 Jan 14;15(1):1089-1096. Epub 2017 Nov 14.

Department of Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai 200433, P.R. China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ol.2017.7411DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5772734PMC
January 2018

Characterization of distinct types of mutation and its impact on first-line platinum-based chemotherapy in Chinese patients with advanced non-small cell lung cancer.

Oncol Lett 2017 Dec 21;14(6):6525-6532. Epub 2017 Sep 21.

Department of Medical Oncology, Shanghai Pulmonary Hospital and Thoracic Cancer Institute, Tongji University School of Medicine, Shanghai 200433, P.R. China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ol.2017.7016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686437PMC
December 2017

Seven-microRNA panel for lung adenocarcinoma early diagnosis in patients presenting with ground-glass nodules.

Onco Targets Ther 2017 13;10:5915-5926. Epub 2017 Dec 13.

Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/OTT.S151432DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732566PMC
December 2017

Uncommon mutations in a cohort of Chinese NSCLC patients and outcomes of first-line EGFR-TKIs and platinum-based chemotherapy.

Chin J Cancer Res 2017 Dec;29(6):543-552

Department of Medical Oncology, Shanghai Pulmonary Hospital & Thoracic Cancer Institute, Tongji University School of Medicine, Shanghai 200433, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21147/j.issn.1000-9604.2017.06.09DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5775013PMC
December 2017

Characterization of Liver Metastasis and Its Effect on Targeted Therapy in EGFR-mutant NSCLC: A Multicenter Study.

Clin Lung Cancer 2017 11 5;18(6):631-639.e2. Epub 2017 May 5.

Division of Hematology, Oncology and Blood and Marrow Transplantation, Department of Internal Medicine, Holden Comprehensive Cancer Center, University of Iowa Carver College of Medicine, Iowa City, IA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2017.04.015DOI Listing
November 2017

Comparison of cross-platform technologies for EGFR T790M testing in patients with non-small cell lung cancer.

Oncotarget 2017 Nov 5;8(59):100801-100818. Epub 2017 Jul 5.

Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University, Tongji University Medical School Cancer Institute, Shanghai, P. R. China.

View Article

Download full-text PDF

Source
http://www.oncotarget.com/fulltext/19007
Publisher Site
http://dx.doi.org/10.18632/oncotarget.19007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725066PMC
November 2017

The changing diagnostic pathway for lung cancer patients in Shanghai, China.

Eur J Cancer 2017 10 17;84:168-172. Epub 2017 Aug 17.

Department of Medicine, Royal Marsden NHS Foundation Trust, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.07.036DOI Listing
October 2017

The role of endobronchial ultrasound elastography in the diagnosis of mediastinal and hilar lymph nodes.

Oncotarget 2017 Oct 6;8(51):89194-89202. Epub 2017 Jul 6.

Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine & Tongji University School of Medicine Thoracic Cancer Institute, Shanghai, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.19031DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687681PMC
October 2017

MHC class II expression in lung cancer.

Lung Cancer 2017 10 29;112:75-80. Epub 2017 Jul 29.

Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, 80045, CO, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2017.07.030DOI Listing
October 2017

Early detection of lung cancer by using an autoantibody panel in Chinese population.

Oncoimmunology 2018 16;7(2):e1384108. Epub 2017 Oct 16.

Department of Medicine, Division of Medical Oncology, University of Colorado Cancer Center, Anschutz Medical Campus, Aurora, CO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2017.1384108DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5749655PMC
October 2017

Comprehensive Analysis of EGFR-Mutant Abundance and Its Effect on Efficacy of EGFR TKIs in Advanced NSCLC with EGFR Mutations.

J Thorac Oncol 2017 09 15;12(9):1388-1397. Epub 2017 Jun 15.

Departments of Medicine and Pathology, University of Colorado Cancer Center, Aurora, Colorado.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2017.06.006DOI Listing
September 2017

Addition of bevacizumab for malignant pleural effusion as the manifestation of acquired EGFR-TKI resistance in NSCLC patients.

Oncotarget 2017 Sep 9;8(37):62648-62657. Epub 2017 Mar 9.

Department of Internal Medicine, Division of Hematology, Oncology and Blood & Marrow Transplantation, Holden Comprehensive Cancer Center, University of Iowa, Carver College of Medicine, Iowa, IA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.16061DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617537PMC
September 2017

Clinical features of Bim deletion polymorphism and its relation with crizotinib primary resistance in Chinese patients with ALK/ROS1 fusion-positive non-small cell lung cancer.

Cancer 2017 Aug 27;123(15):2927-2935. Epub 2017 Mar 27.

Department of Medical Oncology, Shanghai Pulmonary Hospital and Thoracic Cancer Institute, Tongji University School of Medicine, Shanghai, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.30677DOI Listing
August 2017

Predictive and prognostic value of folate receptor-positive circulating tumor cells in small cell lung cancer patients treated with first-line chemotherapy.

Oncotarget 2017 Jul;8(30):49044-49052

Department of Medical Oncology, Shanghai Pulmonary Hospital, Thoracic Cancer Institute, Tongji University School of Medicine, Shanghai, 200433, P.R. China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.17039DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564747PMC
July 2017

Combined Radiotherapy and Anti-PD-L1 Antibody Synergistically Enhances Antitumor Effect in Non-Small Cell Lung Cancer.

J Thorac Oncol 2017 07 3;12(7):1085-1097. Epub 2017 May 3.

Department of Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2017.04.014DOI Listing
July 2017

Comparison of laboratory testing methods for the diagnosis of tuberculous pleurisy in China.

Sci Rep 2017 07 3;7(1):4549. Epub 2017 Jul 3.

Soochow University, Suzhou, 215006, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-017-04872-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5495749PMC
July 2017

Imaging features of TSCT predict the classification of pulmonary preinvasive lesion, minimally and invasive adenocarcinoma presented as ground glass nodules.

Lung Cancer 2017 06 27;108:192-197. Epub 2017 Mar 27.

Department of Imaging, Shanghai Pulmonary Hospital, Tongji University, Tongji University Medical School Cancer Institute, Shanghai, PR China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2017.03.011DOI Listing
June 2017

Transcutaneous electrical acupoint stimulation (TEAS) ameliorates chemotherapy-induced bone marrow suppression in lung cancer patients.

J Thorac Dis 2017 Mar;9(3):809-817

Department of Oncology, Shanghai Pulmonary Hospital of Tongji University, Shanghai 200043, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/jtd.2017.03.12DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5394020PMC
March 2017